• Betel quids raise pharma concerns in Bangladesh
    Chewing betel quids could lead Bangladeshi people to need pharma intervention

Bioanalytical

Betel quids raise pharma concerns in Bangladesh

Feb 08 2011

Pharma firms operating in Bangladesh must contend with relatively high levels of poisons including arsenic and manganese in the groundwater supply, note researchers writing in BMC Public Health.

The team from Leicester's De Montfort University explain that excessive manganese exposure can cause negative health effects similar to those seen in Parkinson's Disease.

However, they have now looked into the possibility of exposure to the element through betel quid chewing, using inductively coupled plasma mass spectrometry to analyse urinary output.

A betel quid consists of chopped areca nut, calcium hydroxide, flavourings such as tobacco leaves and an outer layer of Piper betel leaves.

Some ten per cent of the world's population chew betel quids on a daily basis, the researchers add.

However, the negative impacts could leave those in Bangladesh requiring pharmaceutical assistance, as they exhibited a 210 per cent increase in manganese concentration in their urine.

BMC Public Health specialises in publishing research pertaining to the epidemiology of disease and its impact on populations in general.

Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

NGVS 2024

May 23 2024 Beijing, China

Analiza

May 28 2024 Tel Aviv, Israel

HTC-18

May 28 2024 Leuven, Belgium

PREP 2024

May 28 2024 Philadelphia, PA, USA

CISILE 2024

May 29 2024 Beijing, China

View all events